Hasanain A, Mahdy R, Mohamed A, Ali M. A randomized, comparative study of dual therapy (doxycycline-rifampin) versus triple therapy (doxycycline-rifampin-levofloxacin) for treating acute/subacute brucellosis. Braz J Infect Dis 2016;20(3):250–4. https://www.ncbi.nlm.nih.gov/pubmed/27086734
Sofian M, Velayati AA, Aghakhani A, McFarland W, Farazi AA, Banifazl M, et al. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial. Scand J Infect Dis 2014;46(8):573–7. https://www.ncbi.nlm.nih.gov/pubmed/24934986
Vrioni G, Bourdakis A, Pappas G, Pitiriga V, Mavrouli M, Pournaras S, et al. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Antimicrob Agents Chemother 2014;58(12):7541–4. https://www.ncbi.nlm.nih.gov/pubmed/25246401
